For Quick Alerts
ALLOW NOTIFICATIONS  
For Daily Alerts

Saamya Biotech (Indi - Outcome of Board Meeting

By Religare
|

Saamya Biotech India Ltd has informed BSE that the Board of Directors of the Company at its meeting held on September 05, 2015, inter alia, has transacted the following items of business :

1. Approved the Directors' Report for the year 2014-15.

2. Considered and recommended the name of Directors of the Company for reappointment.

3. Recommended the name of retiring auditors for re-appointment as Statutory Auditors.

4. Mr. Manish Kumar Singhania, Company Secretary in Practice, has been appointed as the Scrutinizer to scrutinize the e-voting process.

5. Recommended to increase in authorized share capital of the company from INR 35 Crores to INR 120 Crores and Alteration in Articles of Association.

6. Recommended to increase in the borrowing powers up to the limit of INR 200 Crores.

7. Recommended to Raise Additional Funds not exceeding INR 100 Crores through QIP/ Warrants/ FCCBs/ FCEBs/Private Placements/GDRs.

8. Recommended to increase the limit for investment by Foreign Institutional Investors (FIIs) up to 80%.















Story first published: Monday, September 7, 2015, 23:00 [IST]
Company Search
Enter the first few characters of the company's name or the NSE symbol or BSE code and click 'Go'

Find IFSC

We use cookies to ensure that we give you the best experience on our website. This includes cookies from third party social media websites and ad networks. Such third party cookies may track your use on Goodreturns sites for better rendering. Our partners use cookies to ensure we show you advertising that is relevant to you. If you continue without changing your settings, we'll assume that you are happy to receive all cookies on Goodreturns website. However, you can change your cookie settings at any time. Learn more